PRILENAP

Tablet, 20mg
RxActive license

Active substance (INN)

enalapril

Pharmaceutical form

Pharmaceutical formTablet
Strength20mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupCardiovascular system (C09AA02)
Marketing authorization holderDRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU "HEMOMONT" ZA PROIZVODNJU FARMACEUTSKIH PROIZVODA PODGORICA
Authorization dateApril 16, 2024

Analogs in Montenegro

7

Other medicines with the same active substance

ENAPRx
Tablet, 5mgKrka d.d.
ENAP-HRx
Tablet, 10mg + 25mgKrka d.d.
ENAP®Rx
Tablet, 10 mgKrka d.d.
ENAP®Rx
Tablet, 20 mgKrka d.d.
PRILENAPRx
Tablet, 10mgHemofarm a.d. Vršac
PRILENAP HRx
Tablet, 10mg + 25mgHemofarm a.d. Vršac
PRILENAP HLRx
Tablet, 10mg + 12.5mgHemofarm a.d. Vršac
Source: CInMED register